Screener
Twist Bioscience Corporation TWST Income Statement
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| $126.64M+27.9% | $118.38M+23.2% | $110.72M+19.3% | $103.7M+16.9% | $99.01M+16.9% | ||
| $59.39M+23.3% | $55.92M+24.9% | $53.59M+14.6% | $49.73M+8.4% | $48.17M+3.6% | ||
| $67.25M+32.3% | $62.45M+21.7% | $57.12M+24.1% | $53.97M+26.0% | $50.84M+33.0% | ||
| 53.1%+1.8pp | 52.8%-0.6pp | 51.6%+2.0pp | 52%+3.8pp | 51.3%+6.2pp | ||
| $16.99M-0.2% | $18.03M-0.1% | $19.7M-17.7% | $17.13M-19.6% | $17.01M-19.5% | ||
| $74.68M+17.1% | $80.71M+27.4% | $76.09M+19.5% | $69.74M+24.1% | $63.76M+20.0% | ||
| $151.06M+17.1% | $154.66M+22.6% | $156.58M+16.5% | $136.6M+10.7% | $128.94M+6.8% | ||
| -$24.41M+18.4% | -$36.28M-20.5% | -$45.86M-10.4% | -$32.9M+5.0% | -$29.93M+16.9% | ||
| -19.3%+11.0pp | -30.6%+0.7pp | -41.4%+3.4pp | -31.7%+7.3pp | -30.2%+12.3pp | ||
| $170K— | $40K+105% | $175K+144% | $471K+606% | —— | ||
| -$20.82M+22.5% | -$34.74M-269% | -$43.98M-12.3% | -$30.25M+3.9% | -$26.88M+22.6% | ||
| —— | $311K+62.8% | $43K-75.4% | $253K+161% | $257K— | ||
| -$20.62M+24.0% | -$35.05M-272% | -$44.02M-11.9% | -$30.51M+3.4% | -$27.14M+21.7% | ||
| -16.3%+11.1pp | -29.6%-50.8pp | -39.8%+2.6pp | -29.4%+6.2pp | -27.4%+13.5pp | ||
| -$0.30+33.3% | -$0.56-270% | -$0.71-7.6% | -$0.50+5.7% | -$0.45+23.7% | ||
| -$17.32M+27.6% | -$29.5M-22.6% | -$39.45M-12.2% | -$26.71M+5.5% | -$23.93M+18.6% | ||
| -13.7%+10.5pp | -24.9%+0.1pp | -35.6%+2.3pp | -25.8%+6.1pp | -24.2%+10.5pp | ||
| -$24.41M+18.4% | -$36.28M-20.5% | -$45.86M-10.4% | -$32.9M+5.0% | -$29.93M+16.9% |
FAQ
- What is Twist Bioscience Corporation's revenue?
- Twist Bioscience Corporation (TWST) generated $459.4M in revenue over the trailing twelve months, up 22.0% year over year.
- Is Twist Bioscience Corporation profitable?
- Twist Bioscience Corporation is not currently profitable: it reported a net loss of $130.2M over the trailing twelve months, a -28.3% net margin.
- What are Twist Bioscience Corporation's profit margins?
- Gross margin is 52.4% and operating margin is -30.4%, with a -28.3% net margin.
- What is Twist Bioscience Corporation's earnings per share?
- Twist Bioscience Corporation's diluted EPS over the trailing twelve months is $-2.07.
- Where does Twist Bioscience Corporation's income statement data come from?
- Every line is extracted from Twist Bioscience Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
